AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2012-12-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 20
- Registration Number
- NCT01504906
- Locations
- 🇺🇸
Research site, Overland Park, Kansas, United States
Faslodex Specific Clinical Experience Investigation
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2011-12-29
- Last Posted Date
- 2016-05-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 660
- Registration Number
- NCT01501266
- Locations
- 🇯🇵
Research Site, Yamanashi, Japan
Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 101
- Registration Number
- NCT01499303
- Locations
- 🇬🇧
Research Site, Southampton, United Kingdom
Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214
Phase 1
Withdrawn
- Conditions
- Drug AbuseHealthy
- Interventions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2012-03-22
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT01500018
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Phase 2
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 171
- Registration Number
- NCT01498185
- Locations
- 🇺🇸
La Biomed Research Inst. At Harbor Ucla Med Ctr., Torrance, California, United States
🇺🇸Va San Diego Healthcare System, San Diego, California, United States
🇺🇸Vince And Associates Clinical Research, Overland Park, Kansas, United States
A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients
Phase 2
Completed
- Conditions
- COPD
- Interventions
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2012-10-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 39
- Registration Number
- NCT01498081
- Locations
- 🇸🇪
Research Site, Lund, Sweden
Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects
Phase 1
Completed
- Conditions
- Bioequivalence Study
- Interventions
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 77
- Registration Number
- NCT01494402
- Locations
- 🇯🇵
Study site, Hakata, Fukuoka, Japan
Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1907
- Registration Number
- NCT01493544
- Locations
- 🇻🇪
Research Site, Valencia, Venezuela
Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia
Completed
- Conditions
- Acute Psychotic EpisodeSchizophrenia
- First Posted Date
- 2011-12-14
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 503
- Registration Number
- NCT01491412
- Locations
- 🇷🇴
Research Site, Iasi, Romania
A NIS Registry of the Prospective Structured Care In Acute Coronary Syndrome
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2011-12-13
- Last Posted Date
- 2014-09-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1006
- Registration Number
- NCT01490645
- Locations
- 🇩🇪
Research Site, Wuerzburg, Germany